28
Participants
Start Date
October 31, 2010
Primary Completion Date
May 31, 2013
Study Completion Date
June 30, 2013
AFM 13
Cohort escalation then expansion phase design. Starting dose 0.01 mg/kg. 4 weekly drug administrations.
University Hospital Würzburg, Würzburg
The University of Texas MD Anderson Cancer Center, Houston
University Hosptial Cologne, Cologne
Lead Sponsor
Affimed GmbH
INDUSTRY